Human & Veterinary Medicine - International Journal of the Bioflux Society
Online ISSN 2066-7663; Print ISSN 2066-7655
Since 1928
Peer-reviewed (each article is independently analyzed by two
specialists).
Published annually by Bioflux Publishing.
The journal covers all fields of human and veterinary
medicine and publishes original papers, short communications, case reports, and
review articles. Each published article is evaluated by two reviewers and at
least one specialist in foreign languages. Peer-review policy: double-blind
peer review. The editors use software that screens for plagiarism. Electronic
submission is required. Authors are informed about the editorial decision
(acceptance or rejection) within 3–8 weeks after submission. The average overall
time from manuscript submission to publication is 10 weeks.
Contact for submission: ioan.mag@usamvcluj.ro
Our journal, HVM Bioflux, offers a good opportunity to
publish papers in a timely manner, in color, both in print and online, open
access, with unlimited pages. The journal allows author(s) to retain copyright
without restrictions.
This is an open-access journal distributed under the terms
of the Creative Commons Attribution License (CC-BY), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited. The journal has no article submission charges. The
journal has a waiver policy for authors from developing countries (only in
cases of very high-quality manuscripts).
For papers submitted since January 2011, a publication fee
of 150 USD or 650 LEI must be paid after acceptance. Authors may choose a
fast-track publication option, enabling publication within less than 3 weeks,
if the article is accepted. In this case, the publication fee is 300 USD or
1200 LEI. When the manuscript’s first author is a member of the Editorial Board
(HVM Bioflux), no publication fee is required.
Please attach a scanned payment document and send it to: ioan.mag@usamvcluj.ro
Some papers require English language editing; the fee for
this service is 50 USD for both members and non-members of the Editorial Board.
Payment to: Bioflux SRL
SWIFT code: BTRLRO22
Account no.: 213USDCRT00L2861401
IBAN:
USD: RO68BTRL01302202L28614XX – BANCA TRANSILVANIA
(Cluj-Napoca)
EURO: RO19BTRL01304202L28614XX – BANCA TRANSILVANIA (Cluj-Napoca)
LEI: RO44BTRL01301202L28614XX – BANCA TRANSILVANIA (Cluj-Napoca)
Rejection rate: 40%.
Historical
The monthly scientific journal Miscarea Medicala was
founded on January 1, 1928, by Dr. M. Canciulescu and his colleagues and
functioned as a private journal throughout its existence. The headquarters of
the publication was located on Unirii Street no. 102–104, Craiova, Romania. The
serial publication ran until 1948 and changed its name several times. In 1930,
the journal supplement became Miscarea Medicala Romaneasca; in 1932, the
serial became Miscarea Medicala Romana; and in 1944, it changed its name
again to Acta Medica Romana. Although the first issues were printed at
Societatea Prietenii Stiintei (Craiova), some subsequent editions appeared
under the aegis of Scrisul Romanesc, Craiova, which later ceased activity.
However, the journal Miscarea Medicala remained an independent private
publication.
The editors of the last volume (1948)—Canciulescu M., Parhon
C.I., Anghelescu C., Ciuca M., Daniel C., Gomoiu V., Danielopolu D.,
Ionescu-Mihaiesti C., Levaditi C., and Nicolau S.—intended to resume
publication of the periodical, but this did not occur. One of the last
surviving editors, Dr. Victor Gomoiu (1882–1960), took over the archive, the
collection, and the publishing rights. After his death, his wife, Mrs. Viorica
Gomoiu (1899–1989), donated the archive, the collection, and the publishing
rights to the History Museum of Medicine and Pharmacy in Craiova, which
functioned within the University of Craiova (Faculty of Medicine) and in
cooperation with the Romanian Committee for the History and Philosophy of
Science and Technology, Craiova branch.
The preservation of the archive and the initiative to
re-edit the publication are due to Professor Mihail Scheau Ph.D., Professor
Gheorghe Manolea Ph.D., and Ion Patrutoiu Ph.D. With their support, in 2007, a
pre-contract was concluded between the Romanian Committee of History and
Philosophy of Science and Technology (Craiova branch) and Bioflux SRL (Bioflux
Publishing House) to unify the national journal Acta Medica Romana with
the international journal projected to appear in 2007 under the name Human
& Veterinary Medicine (HVM Bioflux). Because Human & Veterinary
Medicine gained significant recognition, in 2016 a definitive contract was
established to unify the two journals and editorial teams.
The digitization of the historical collection was carried
out through a contract between Bioflux Publishing House (Bioflux SRL) and the
Central University Library “Lucian Blaga,” Cluj-Napoca.
Human & Veterinary Medicine is now a biomedical serial publication with one issue per year, coordinated by Editor-in-Chief Stefan Cristian Vesa Ph.D. and Director Ioan Valentin Petrescu-Mag Ph.D..
Statement of human and animal rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed (International Committee of Medical Journal Editors - "Uniform Requirements for Manuscripts Submitted to Biomedical Journals"- February 2006 – cited by Pubmed, Medline database).
Statement of informed consent
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note (International Committee of Medical Journal Editors - "Uniform Requirements for Manuscripts Submitted to Biomedical Journals"- February 2006 – cited by Pubmed, Medline database).
Conflict-of-interest statement
Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself (International Committee of Medical Journal Editors - "Uniform Requirements for Manuscripts Submitted to Biomedical Journals"- February 2006 – cited by Pubmed, Medline database). However, conflicts can occur for other reasons, such as personal relationships, academic competition or intellectual passion, and the Chief Editor will do his best to avoid them, using specific policies in the process of peer-review.
Authors responsibilities
- All authors have significantly contributed to the research
- All authors are obliged to provide retractions or
corrections of mistakes, in case of detection
- List of references should be provided by authors
- Information on financial support should be provided by
authors in Acknowledgement section
- It is forbidden to publish same research in more than one journal.
Peer-review, publication policies and publication ethics
- Judgments is external and objective
- Reviewers have no conflict of interest
- Reviewed articles are treated confidentially prior to
their publication
- Bioflux Publishing House takes reasonable steps to
identify and prevent the publication of papers where research misconduct has
occurred
- In the event that the publisher or editors are made aware
of any allegation of research misconduct the publisher or editor shall deal
with allegations appropriately
- Corrections, clarifications, retractions and apologies are
accepted. Correction of any published article after the official publication
date is not allowed in the same document. A scientific journal is not a
website. Corrections, clarifications and apologies written by the authors are
allowed by separate Note or Erratum. Retracting of a manuscript is made by
publisher in the case when plagiarism or other particular issues are reported.
- This is an open-access journal distributed under the terms
of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and
source are credited.
- In the case that our journal is no longer published,
Bioflux Publishing House has agreements with several databases which are
allowed to conserve and republish the old content at any time and unlimited
number of copies, both as electronic and hardcopies. Bioflux Publishing House
is archived by The Legal Deposit Bucharest (National Library) and by The County
Legal Deposit in Cluj-Napoca (Octavian Goga Library).
Data Sharing Policy
1. Policy Statement
HVM Bioflux is committed to
promoting transparency, reproducibility, and integrity in scientific research.
We support responsible data sharing as an essential component of scholarly
communication and encourage authors to make the data underlying their findings
openly available whenever possible.
This policy applies to all
manuscripts submitted to the journal and is consistent with international
standards for editorial best practices and research transparency.
2. Author Responsibilities
Authors are required to:
- Include
a Data Availability Statement in all submitted manuscripts.
- Clearly
indicate whether the data supporting the findings of the study are:
- Publicly
available,
- Available
upon reasonable request, or
- Restricted
due to ethical, legal, or confidentiality considerations.
- Ensure
that shared data are accurate, complete, and sufficiently documented to
allow replication and verification of the reported results.
Authors are strongly encouraged to deposit their data in recognized public repositories appropriate to their discipline.
3. Data Availability Statement
All manuscripts must include a
Data Availability Statement specifying one of the following:
- The
repository name, persistent identifier (e.g., DOI), and access link if
data are publicly available.
- The
conditions under which data may be accessed if restrictions apply.
- A
clear explanation if no new data were generated or analyzed.
Example statement:
"The data supporting the findings of this study are available in [repository name] at [DOI or URL], or from the corresponding author upon reasonable request."
4. Recommended Data
Repositories
Authors are encouraged to use
trusted repositories that provide:
- Persistent
identifiers (e.g., DOI)
- Long-term
preservation
- Public
accessibility
- Appropriate
metadata and documentation
Examples include institutional repositories, discipline-specific repositories, or general repositories such as Zenodo, Dryad, Figshare, or equivalent platforms.
5. Ethical and Legal
Considerations
Data sharing must comply with:
- Patient
privacy and confidentiality requirements
- Informed
consent provisions
- Institutional
and national regulations
- Ethical
approval conditions
Sensitive data involving human
participants must be de-identified prior to sharing, unless explicit consent
for identifiable data sharing has been obtained.
Where legal or ethical restrictions prevent public sharing, authors must clearly state these limitations.
6. Editorial and Peer Review
Access
Editors and peer reviewers may
request access to underlying data during the review process to evaluate the
scientific validity of the manuscript. Authors must provide such data upon
request, unless prohibited by legal or ethical constraints.
Failure to provide requested data may result in rejection of the manuscript.
7. Compliance and Enforcement
Failure to comply with this
policy may result in:
- Manuscript
rejection,
- Publication
delays,
- Retraction
of published articles if data integrity concerns arise.
The journal reserves the right to request data verification at any stage before or after publication.
8. Exceptions
Exceptions to data sharing
requirements may be granted in cases involving:
- Legal
restrictions,
- Ethical
or privacy concerns,
- Proprietary
or confidential data.
Such exceptions must be clearly justified in the Data Availability Statement.
9. Policy Scope and Alignment
This policy is aligned with
international editorial standards and supports the principles of:
- Research
transparency
- Reproducibility
- Scientific
integrity
- Responsible
data stewardship
The journal periodically reviews and updates this policy to maintain compliance with evolving indexing and ethical standards.
10. Contact Information
Questions regarding this policy
should be directed to the Editorial Office at:
ioan.mag@usamvcluj.ro
Advertising policy
Our journals do not accept or display any form of advertising, sponsored content, or commercial promotions. No third-party advertising networks are used, and there is no advertising revenue associated with our publications.
HVM Bioflux
Volume 19(1)/2027 (December, 30)
Volume 18(1)/2026 (December, 30)
Volume 17(1)/2025 (December, 30)
Volume 16(1)/2024 (December, 30)
Volume 15(2)/2023 (December, 30)
Volume 14(4)/2022 (December, 30)
Volume 14(3)/2022 (September, 30)
Volume 13(4)/2021 (December, 30)
Volume 13(3)/2021 (September, 30)
Volume 12(4)/2020 (December, 30)
Volume 12(3)/2020 (September, 30)
Volume 11(4)/2019 (December, 30)
Volume 11(3)/2019 (September, 30)
Volume 10(4)/2018 (December, 30)
Volume 10(3)/2018 (September, 30)
Volume 9(4)/2017 (December, 30)
Volume 9(3)/2017 (September, 30)
Special Issue/2016 (December, 31)
Volume 8(4)/2016 (December, 30)
Volume 8(3)/2016 (September, 30)
Volume 7(4)/2015 (December, 30)
Volume 7(3)/2015 (September, 30)
Special Issue/2014 (December, 30)
Volume 6(4)/2014 (December, 30)
Volume 6(3)/2014 (October, 30)
Volume 5(3)/2013 (December, 30)
Volume 4(3)/2012 (December, 30)
Volume 4(2)/2012 (September, 30)
Volume 3(3)/2011 (December, 30)
Volume 3(2)/2011 (November, 30)
Volume 2(2)/2010 (December, 30)
Volume 1(2)/2009 (December, 30)
Pilot (b)/2008 - Available printed only
Pilot (a)/2007 - Available printed only
1940 Supplement - Table of Content
